Pathological Complete Response to Nab-Paclitaxel–Containing Neoadjuvant Regimens in Early Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
Background: Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with limited targeted treatment options. This systematic review and meta-analysis evaluated pathological complete response (pCR) outcomes associated with nab-paclitaxel-containing neoadjuvant regimens incorporating platinum chemothe...